logo

For the Inventor, By the Inventor

Nashville, TN, United States of America

Lawrence J Marnett

This inventor holds 27 USPTO granted patents and 4 published patent applications and 1 EPO patent, primarily in Cancer Therapeutics. Top assignees: Vanderbilt University, University of Pennsylvania, Wayne State University. Active years: 1988-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence J Marnett. Retrieved from https://idiyas.com/inventor/lawrence-j-marnett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 70.4

 

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 185(Granted Patents)


Location History:

  • Pleasant Ridge, MI (US) (1988)
  • Brentwood, TN (US) (1993 - 1995)
  • Nashville, TN (US) (1993 - 2023)

Company Filing History:

goldMedal25 out of 1,221 
 
Vanderbilt University
 patents
silverMedal5 out of 2,659 
 
University of Pennsylvania
 patents
bronzeMedal2 out of 603 
 
Wayne State University
 patents
4. 1 out of 4 
 
Biomide Investment Limited Partnership
 patents
5. 1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Castrate-Resistant Prostate Cancer
COX-2 Inhibitors
Antiangiogenic Agents
Imaging Cancer
Hypoxia Detection
Cyclooxygenase Activity
Indomethacin Analogs
Aryl Aliphatic Acids
Selective Inhibitors
Amide Derivatives
2-Arachidonylglycerol Metabolites
Indolealkylamides
27 patents (USPTO):Explore Patents
1. 11738004 - Indomethacin analogs for the treatment of castrate-resistant prostate cancer (2023-08-29),
2. 11459295 - 2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same (2022-10-04),
3. 10792377 - Compounds and method for imaging cancer (2020-10-06),
4. 10695446 - Composition and method for detecting hypoxia (2020-06-30),
5. 10398678 - Indomethacin analogs for the treatment of castrate-resistant prostate cancer (2019-09-03),
6. 10105455 - Fluorocoxib A loading into ROS-responsive nanoparticles (2018-10-23),
7. 9895351 - Indomethacin analogs for the treatment of castrate-resistant prostate cancer (2018-02-20),
8. 9346803 - Indomethacin analogs for the treatment of castrate-resistant prostate cancer (2016-05-24),
9. 8865130 - Methods and compositions for diagnostic and therapeutic targeting of COX-2 (2014-10-21),
10. 8168656 - Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity (2012-05-01),
11. 8143302 - Methods and compositions for diagnostic and therapeutic targeting of COX-2 (2012-03-27),
12. 7736624 - Methods and compositions for diagnostic and therapeutic targeting of COX-2 (2010-06-15),
13. 7628975 - Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylgycerol metabolites (2009-12-08),
14. 7491744 - Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity (2009-02-17),
15. 7314709 - Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism (2008-01-01),

Title: The Innovative Journey of Lawrence J Marnett

Introduction: Lawrence J Marnett is a distinguished inventor based in Nashville, Tennessee. With a passion for scientific discovery and a keen eye for innovation, Marnett has made significant contributions to the field of patents and inventions.

Latest Patents: Lawrence J Marnett holds several groundbreaking patents in the areas of biotechnology and pharmaceuticals, showcasing his commitment to advancing scientific knowledge and technology.

Career Highlights: Throughout his illustrious career, Marnett has been recognized for his pioneering work in developing novel compounds for the treatment of various diseases. His innovative approach to research has led to the creation of life-changing medications that have improved the quality of life for countless individuals.

Collaborations: Lawrence J Marnett has collaborated with leading research institutions, pharmaceutical companies, and universities around the world. His collaborative efforts have resulted in the successful development of cutting-edge technologies and treatments that have had a lasting impact on the field of medicine.

Conclusion: Lawrence J Marnett's dedication to innovation and his relentless pursuit of scientific excellence have solidified his reputation as a visionary inventor. His contributions to the world of patents and inventions continue to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…